Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 16.20 is 161% above its 5-year average of 6.22, around the middle of its 5-year range (0.06–23.81).
As of the fiscal period ended Tuesday, June 30, 2026. 11.47% below its 12-month average of 18.30.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.20.
QUICK RATIO (ACID-TEST)
16.20
QUICK RATIO (ACID-TEST) AVG TTM
18.30
QUICK RATIO (ACID-TEST) AVG 3Y
9.31
QUICK RATIO (ACID-TEST) AVG 5Y
6.22
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.47%
CURRENT VS 3Y AVG
+74.03%
CURRENT VS 5Y AVG
+160.59%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.00
median of 672 covered companies
CURRENT VS SECTOR MEDIAN
+439.87%
vs the sector median at left
Aclarion, Inc.
Market Cap
$6.66M
Quick Ratio (Acid-Test)
16.20
TTM Avg
18.30
3Y Avg
9.31
5Y Avg
6.22
Market Cap
$6.62M
Quick Ratio (Acid-Test)
10.21
TTM Avg
3.61
3Y Avg
3.34
5Y Avg
4.20
Market Cap
$6.49M
Quick Ratio (Acid-Test)
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
Market Cap
$6.39M
Quick Ratio (Acid-Test)
N/A
TTM Avg
2.00
3Y Avg
1.31
5Y Avg
1.05
Market Cap
$7.02M
Quick Ratio (Acid-Test)
0.31
TTM Avg
1.26
3Y Avg
1.91
5Y Avg
5.52
Market Cap
$7.13M
Quick Ratio (Acid-Test)
1.52
TTM Avg
3.93
3Y Avg
10.24
5Y Avg
10.80
Market Cap
$6.21M
Quick Ratio (Acid-Test)
0.93
TTM Avg
1.44
3Y Avg
2.71
5Y Avg
3.16
Market Cap
$6.98M
Quick Ratio (Acid-Test)
0.18
TTM Avg
0.90
3Y Avg
2.06
5Y Avg
1.76
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclarion, Inc. (ACON) | $6.66M | 16.20 | 18.30 | 9.31 | 6.22 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.62M | 10.21 | 3.61 | 3.34 | 4.20 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.49M | 2.61 | 3.40 | 4.86 | 5.09 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.39M | N/A | 2.00 | 1.31 | 1.05 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.02M | 0.31 | 1.26 | 1.91 | 5.52 |
| Femasys Inc. (FEMY)vs › | $6.19M | 0.55 | 1.77 | 4.96 | 6.03 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.13M | 1.52 | 3.93 | 10.24 | 10.80 |
| Biomerica, Inc. (BMRA)vs › | $6.21M | 0.93 | 1.44 | 2.71 | 3.16 |
| Mangoceuticals, Inc. (MGRX)vs › | $6.98M | 0.18 | 0.90 | 2.06 | 1.76 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.05M | 17.15 | 11.86 | 7.50 | 9.06 |
Quick Ratio
16.20
Excludes inventory
Current Ratio
16.20
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 16.20 |
| 2026-03-31 | 19.65 |
| 2025-12-31 | 14.81 |
| 2025-09-30 | 17.01 |
| 2025-06-30 | 23.81 |
| 2025-03-31 | 21.68 |
| 2024-12-31 | 0.71 |
| 2024-09-30 | 2.79 |
| 2024-06-30 | 1.28 |
| 2024-03-31 | 2.08 |
| 2023-12-31 | 0.40 |
| 2023-09-30 | 0.15 |
| 2023-06-30 | 0.40 |
| 2023-03-31 | 0.92 |
| 2022-12-31 | 2.47 |
| 2022-09-30 | 2.46 |
| 2022-06-30 | 3.17 |
| 2022-03-31 | 0.06 |
| 2021-12-31 | 0.10 |
| 2021-09-30 | 0.12 |
| 2021-06-30 | 0.23 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.01 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
